Breast Cancer Coverage from Every Angle

Published Medical Literature

Cost-Effectiveness of Breast Cancer Therapy: Learning From New Utility Values
Early-Stage Triple-Negative Breast Cancer: Link Between TILs and Survival?
Using Breast Cancer Index to Make Decisions About Extended Endocrine Therapy
Neuropilin-1: A Potential Biomarker and Therapeutic Target in Triple-Negative Breast Cancer?
After Radiotherapy for Breast Cancer: Are Patients at Higher Risk for Certain Skin Cancers?
Contralateral Prophylactic Mastectomy: Impact of Racial Disparities
Triple-Negative Breast Cancer CNS Metastases: Repurposing an Older Drug for New Use
Composition of Peripheral Leukocytes in Breast Cancer Survivors: Clinical Implications
Use of an AI Model to Predict 5-Year Breast Cancer Risk From Mammograms
Study Suggests Potential Impact of Housing Discrimination on Outcomes in Breast Cancer
Early-Stage Breast Cancer: Phase III Interim Analysis of Ribociclib Combination Therapy
Prognostic Value of Lactylation-Related Genes in Patients With Breast Cancer
Mapping the Molecular Framework of Rare Phyllodes Breast Tumors
Copper-Related Genes and Response to Trastuzumab in HER2-Positive Disease
Can Targeting the TACC3 Protein Improve Responses to T-DM1 in HER2-Positive Breast Cancer?
Dermatitis From Radiotherapy for Breast Cancer: Keratin-Based Topical Cream Under Study
Shared Decision-Making and Patient Engagement in Breast Cancer Treatment Decisions
Denosumab Therapy and Cardiovascular Morbidity in Patients With Breast Cancer
How Cost-Effective Is Adjuvant Therapy With Olaparib in Breast Cancer?
CKD4/6 Inhibition and Endocrine Therapy vs Chemotherapy for Metastatic Breast Cancer
Cancer Funding Disparities: Implications for Equity, Research, and Clinical Trials
Soy Isoflavones and Recurrence of Breast Cancer
Predicting Overall Survival in Nonmetastatic Breast Cancer With Novel Prognostic Tool
Clinical Decision-Making in Elderly Women With Early-Stage Breast Cancer: A UK Perspective
Flaxseed Lignans and Gut Microbiota: Novel Route for Breast Cancer Prevention?
Modified Radical Mastectomy vs Oncoplastic Breast-Conserving Surgery: Quest for Recurrence Risk Model
Teaming AI With Implant-Based Breast Reconstruction to Help Predict Risk for Infection
ER Antagonist With and Without Palbociclib Under Study in Breast Cancer
How Reliable Is Tumor Bed Biopsy in Predicting Treatment Response in Breast Cancer?
Is Dandelion and ATRA Combination Cytotoxic to Breast Cancer Cells?
After Mastectomy: Comparing Conventional and Hypofractionation Proton Radiotherapy
Real-World vs PALOMA-2 Results With Palbociclib and Aromatase Inhibitors in Breast Cancer
Adding Ovarian Suppression to Tamoxifen to Reduce Recurrence in Younger Women With Breast Cancer
Heart of the Matter: Cardiac Rehabilitation After Chemotherapy for Early-Stage Breast Cancer
Connection Between Obesity and Breast Cancer Prognosis: More Data Emerge
After Neoadjuvant Therapy for Node-Positive Breast Cancer: Is ALND Always Necessary?
Predicting Breast Cancer–Related Lymphedema Among Women of Different Races
Breast Cancer Subtypes and Locoregional Recurrence: Tailoring Surveillance to Improve Patient Outcomes
Unlocking the Genetic Complexity of Breast Cancer: Focus on Rare Haplotypes
Is the Schonberg Index Effective in Evaluating Mortality Risk Among Older Women With Breast Cancer?
Is Family History Associated With Breast Cancer Prognosis in Sweden?
Is Apatinib Combined With Oral Etoposide Feasible for Patients With Triple-Negative Breast Cancer?
Can Exercise Improve Insomnia in Patients Being Treated for Breast Cancer? Researchers Aim to Find Out
Social Determinants of Health and Racial Disparities: Impact on Cardiac Event Outcomes in Breast Cancer
Dalpiciclib Plus Letrozole or Anastrozole Under Study in Advanced Breast Cancer
Researchers Share Plan to Improve Genetic Testing and Counseling in Patients With Breast Cancer
Use of Radiopathomics Model to Predict Response to Neoadjuvant Chemotherapy for Breast Cancer
Cell-Assisted Lipotransfer Versus Conventional Lipofilling for Breast Reconstruction After Radiotherapy
Study Finds Low Rates of Germline Genetic Testing After Cancer Diagnosis in California and Georgia
Comparison of Capivasertib Plus Fulvestrant Versus Fulvestrant Alone in Advanced Breast Cancer
How Does Treatment of Breast Cancer Affect Serum Lipid Composition?
Preclinical Study Identifies Potential Therapeutic Target for Resistance to Radiotherapy in Breast Cancer
Is There a Correlation Between Multimodal Ultrasound Features and Molecular Breast Cancer Subtypes?
Ipsilateral Multifocal Primary Breast Cancer: Pathologic Assessment Using IHC
Role of Preoperative MRI in Breast-Conserving Surgery
Use of Lower-Dose Alternative Schedules of Exemestane in ER-Positive Breast Cancer
Do High-Deductible Health Insurance Plans Influence Patients’ Decisions to Undergo Breast Cancer Screening?
Novel Imaging Approach Under Study to Distinguish Benign From Malignant Breast Tumors
Alisertib Monotherapy Versus Alisertib Plus Fulvestrant in Endocrine-Resistant Advanced Breast Cancer
Novel Strategy to Prevent Acute Radiation Dermatitis in High-Risk Patients With Breast Cancer
Slight Differences in Patient Age May Lead to Different Treatment Recommendations in Early-Stage Breast Cancer
Young Women With HR-Positive Breast Cancer: A Case for Genomic Characterization
Study Finds Racial and Ethnic Disparities in Colorectal Cancer Screening Among Breast Cancer Survivors
Assessing the Risk of Future Contralateral Breast Cancer in Carriers of Certain Germline Pathogenic Variants
Novel BRCA2 Mutation Strengthens Evidence for Germline Genetic Testing
Black Breast Cancer Survivors and the Psychosocial Challenges They Face
Palbociclib’s Benefits in Metastatic Breast Cancer Assessed in Real-World Analysis
Does a Certain Protein Complex Contribute to Endocrine Resistance in Breast Cancer?
Medicaid Expansion in Southern U.S. States and Breast Cancer
Preventing Hyperglycemia in Patients Being Treated for Advanced Breast Cancer
Use of a Plasmid DNA Vaccine in Treatment of Advanced, HER2-Positive Breast Cancer
Can Patients With Invasive Breast Cancer Who Respond to Neoadjuvant Chemotherapy Avoid Surgery?
New Metabolic Biomarkers May Improve the Ability to Predict Breast Cancer Recurrence
Expanding the Use of PARP Inhibitors in Breast Cancer: Focus on Talazoparib and PALB2
Phase III Trial of Sacituzumab Govitecan in HR-Positive, HER2-Negative Advanced Breast Cancer
Neoadjuvant Chemotherapy and the Immune Landscape in Early-Stage Breast Cancer
Early-Stage Breast Cancer: Use of Contraception in Premenopausal Patients
Targeting ABL-Dependent Brain Metastatic Targets in HER2-Positive Breast Cancer
Pembrolizumab Plus Chemotherapy for Advanced Triple-Negative Breast Cancer: KEYNOTE-355
Chronic Inflammation and Cognitive Problems: Potential Link in Older Breast Cancer Survivors
Treating Non–Low-Risk Ductal Carcinoma In Situ With Tumor Bed Boost After Whole-Breast Irradiation
Could Digital Breast Tomosynthesis Provide Better Screening Than Digital Mammography?
Batwing Mastopexy and Aesthetic Outcomes for Patients With Breast Cancer
Study Finds Breast Tissue Features on MRI May Be Linked to Risk for Second Breast Cancer
IMpassion050 Trial: Combining Standard of Care With Immunotherapy for High-Risk Breast Cancer
Performance of Diagnostic Mammography Seems to Vary Across Racial/Ethnic Groups
Does Receipt of Genetic Counseling Make Uptake of Genetic Testing in Breast Cancer More Likely?
Are Vaginal Estrogen and Menopausal Hormonal Therapies Linked to an Increased Risk of Breast Cancer Recurrence?
GeparX Trial: Adding Denosumab to Nab-Paclitaxel Regimens in Breast Cancer
Is the von Willebrand Factor Linked to Metastasis of Breast Cancer?
COVID-19 and Breast Cancer: Impact on Surgical Treatment and Breast Reconstruction
Trends in Racial Disparity in Breast Cancer Mortality in the United States
Is Etirinotecan Pegol Superior to Chemotherapy in Treating Brain Metastases From Breast Cancer?
A Possible Biological Mechanism Connecting Type 2 Diabetes and Breast Cancer?
Predicting Breast Cancer Using Digital Breast Tomosynthesis Screening: A Risk Model
Ratiometric Combination Nanoprodrug Strategy Under Study in Triple-Negative Breast Cancer
Is There a Link Between Vitamin D Levels and Breast Cancer in Multiethnic/Racial Groups?
Sodium Levels in Breast Cancer: Predicting Tumor Aggressiveness and Therapeutic Response
Can Cytosine and Guanine Nucleotide Pairs Influence Epigenetic Aging of Breast Tissue?
Surveillance Mammography in Older Breast Cancer Survivors: Patient Survey Findings
Compression Sleeves Used Prophylactically May Reduce or Delay Breast Cancer–Related Lymphedema
Pyrotinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer: Phase II PERMEATE Trial
Use of Adjuvant Trastuzumab After Surgery to Reduce Recurrence of Breast Cancer
Is the Acne Medication Spironolactone Linked to Increased Risk for Breast Cancer?
KEYNOTE-522: Event-Free Survival With Pembrolizumab in Triple-Negative Breast Cancer
Gene Amplification: Novel Strategy Against Drug Resistance in HER2-Positive Breast Cancer
Which Genetically Predisposed Older Women Should Undergo Breast Cancer Screening?
Dietary Acid Load and Associated Mortality After Breast Cancer on Long Island, New York
Potential Link Between Insomnia and Its Treatment and Risk of Breast Cancer in Women?
Comparing Palbociclib-Based Therapies in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer
CDK4/6 Inhibitor Plus Fulvestrant and Overall Survival in Breast Cancer: FDA Pooled Analysis
Can Skin Electrical Resistance Be Used as a Screening Tool for Breast Cancer?
HER2-Targeted Therapies With SRS for Breast Cancer Metastatic to the Brain
5-Year Results With Intraoperative Radiotherapy Among Black Women With Breast Cancer
Neoadjuvant Dual Anti-HER2 Therapy for HER2-Positive Breast Cancer: Long-Term Outcomes After Surgery
Chromosomal Instability: Biomarker for Predicting Response to Paclitaxel in Breast Cancer?
Early-Phase Study of Cabozantinib Plus Atezolizumab in Advanced Triple-Negative Breast Cancer
Intratumoral Immune Therapy for Recurrent Breast Cancer
Does Internal Mammary Node Irradiation Improve Outcomes in Node-Positive Breast Cancer?
Persistent Chemotherapy-Induced Alopecia: Is It Partially Reversible in Breast Cancer Survivors?
One Drug or Two for Metastatic Breast Cancer? The Decision May Depend on Serum Enzymes
Pyrotinib Under Study in Metastatic HER2-Positive Breast Cancer With Brain Metastasis
Dosing Intervals of Vinorelbine Under Study in HER2-Negative Breast Cancer
OlympiA: Adjuvant Olaparib for HER2-Negative Early Breast Cancer With BRCA1 or BRCA2 Germline Mutation
Real-World View From Germany: Bevacizumab-Containing Therapy for Locally or Metastatic Breast Cancer
Active Living After Cancer: Exercise Program for Underserved Breast Cancer Survivors
Fulvestrant or Exemestane After Adjuvant Therapy for Advanced Breast Cancer
Investigating Racial Disparities in Survival Outcomes Among Women Treated for Breast Cancer in Atlanta
HER2-Low–Positive Tumors: A New Subgroup of Breast Cancers Identified by IHC?
Reducing Levels of CA 15-3 With Metformin in Patients With Early-Stage Breast Cancer
COVID-19 and Breast Cancer Screening: View From a San Francisco Safety-Net Hospital
Can Behavioral Therapy Relieve Headaches for Breast Cancer Survivors?
ERBB2-Positive Breast Cancer: How Does T-DM1 Measure Up Against Standard Neoadjuvant Treatment?
Stem Cell–Derived Dendritic Cells With Radiotherapy Under Study in Preclinical Breast Cancer Models
COVID-19 and Breast Cancer Screening: Who Is at Risk for Delayed Mammography?
Adjuvant Treatment of Early-Stage Breast Cancer: T-DM1 Versus Paclitaxel Plus Trastuzumab
Early Breast Cancer: 5 Years Versus 3 Years of Adjuvant Bisphosphonate Treatment
Chemotherapy De-escalation Strategy Under Study in Early HER2-Positive Breast Cancer
Preclinical Study of Lasofoxifene in Endocrine Therapy–Resistant Breast Cancer
Prevalence of Germline Pathogenic Variants in Black Women Versus Non-Hispanic White Women
COVID-19 and Breast Cancer Screening in Washington State: Did Socioeconomics Play a Role?
Can Tumor Marker Help to Predict Response to HER2 Inhibition in Breast Cancer?
Early Estrogen Receptor–Positive Breast Cancer: Are Older Women Being Overtreated?
Racial Disparities in Mortality Risk for Women With Triple-Negative Breast Cancer
Aspirin, Clopidogrel, and Risk of Breast Cancer in Postmenopausal Women
PRADA Trial: Is Routine Cardioprotection Required With Early Breast Cancer Therapy?
Are All Triple-Negative Breast Cancers Created Equal?
ASCENT Trial: Antibody-Drug Conjugate Improves Outcomes in Triple-Negative Breast Cancer
Ribociclib-Based Therapy for Advanced Breast Cancer Under Study
Can Salpingo-oophorectomy Reduce the Likelihood of Breast Cancer in High-Risk Women?
Can PET-Based Estradiol Challenge Test Monitor Response to Endocrine Therapy?
Breast Tumor Microenvironment: Differences in Black Women?
Consecutive Mammography Screening and Risk of Breast Cancer Mortality
Common Pathogenic Variants in Breast and Ovarian Cancers: From a Caribbean Perspective
KEYNOTE-119: Pembrolizumab Versus Chemotherapy in Triple-Negative Breast Cancer
Lifetime Smoking and the Risk for Breast Cancer
Revelations About Genes Linked, and Not Linked, to Breast Cancer: Population-Based Study
Are Breast Cancer Survivors at Increased Risk for Cardiovascular Diseases?
Does Use of Aspirin Improve Outcomes in Older Patients With Breast Cancer?
Are National Screening Targets Being Achieved for Breast Cancer?
Can Older Women With Triple-Negative Breast Cancer Benefit From Adjuvant Chemotherapy?
Can Low-Dose Capecitabine Maintenance Improve Outcomes in Triple-Negative Breast Cancer?
PEARL Trial in Metastatic Breast Cancer: Palbociclib Plus Endocrine Therapy Versus Capecitabine
Using Ki67 Index to Select Appropriate Adjuvant Therapy for Early Breast Cancer
Strategy for Reducing Fatigue in Breast Cancer Survivors: Combined Exercise and Mindfulness Training
Does Fertility Preservation Increase Childbirth Rates in Women With Breast Cancer?
Access to the Affordable Care Act and Breast Cancer Diagnosis: Pennsylvania Perspective
Accelerated Partial-Breast Versus Whole-Breast Irradiation in Early Breast Cancer
Adding ErbB Inhibitor to Standard Chemotherapy for HER2-Positive Breast Cancer
Effect of Chemotherapy on Quality of Life of Older Women With Breast Cancer
Novel DNA Repair–Related Gene Prognostic Model for Patients With Breast Cancer
Use of Abbreviated Breast MRI to Screen for Breast Cancer in Women With Dense Breasts
Pembrolizumab Plus T-Cell Inducer Under Study in Triple-Negative Breast Cancer
Update on Systemic Therapies for Breast Cancer: ‘Pragmatic Decision-Making’ Still Needed
Impact of Early Mammographic Screening on Breast Cancer Mortality: UK Age Trial
Ribociclib Plus Fulvestrant With or Without PI3K Inhibitor in Advanced Breast Cancer
Repurposing Aspirin for Chemoresistant Breast Cancer Cells
Trastuzumab Monotherapy for Older Patients With HER2-Positive Breast Cancer
Adverse Opioid-Related Events in Older Breast Cancer Survivors
Chemotherapy-Induced Neutropenia: Alternative Treatment Under Study in Early-Stage Breast Cancer
Researchers Identify Three New Genetic Variants Linked to Male Breast Cancer
Considerations in the Locoregional Treatment of Patients With Early-Stage Breast Cancer
Early-Stage Breast Cancer: Treatment Choices for Women With Young Children
Efficacy of Chemotherapy Plus Checkpoint Inhibition in Metastatic Breast Cancer Under Study
Triple-Negative Breast Cancer: Mixed 19-Peptide Vaccine Monotherapy
Search for Optimal Dose of Nab-paclitaxel for Older Patients With Advanced Breast Cancer
Early Breast Cancer or DCIS: Hypofractionated Versus Standard-Fractionated Radiotherapy
Does Timing of Neoadjuvant Chemotherapy Affect Outcomes in Early-Stage Breast Cancer?
Opioid Use After Surgical Resection of Breast Cancer
Are Circadian Disruption and Breast Carcinogenesis Related?
CHK1 Inhibitor in BRCA Wild-Type Triple-Negative Breast Cancer
Music May Help Women in Chemotherapy for Breast Cancer
CLCA2 Expression: Prognostic Biomarker for Triple-Negative Breast Cancer in Black Women?
Lessons From NALA: Biomarkers of Treatment Response in Metastatic Breast Cancer
Does Exercise Improve Outcomes in Patients Treated for High-Risk Breast Cancer?
Patient-Reported Barriers to Discussing Sexual Concerns With Health-Care Providers
Quality of Life During Pembrolizumab Treatment for Metastatic Triple-Negative Breast Cancer
Subcutaneous Versus Intravenous Pertuzumab/Trastuzumab in Early Breast Cancer: Patient Perspective
Phase III Trial of Triplet Regimen for HER2-Positive Metastatic Breast Cancer
Combination of Abemaciclib, Pembrolizumab, and Anastrozole in Metastatic Breast Cancer
Ipatasertib Plus Paclitaxel in Triple-Negative Breast Cancer: Final Results of LOTUS Trial
Link Between Polypharmacy and Inpatient Hospitalization in Older Patients With Breast Cancer?
Identifying Cancer in Dense Breasts: Abbreviated MRI Versus 3D Mammography
Does Neoadjuvant Chemotherapy Streamline Breast Cancer Treatment?
Updated ASCO Guidelines on Male Breast Cancer: Different Approaches for Men and Women?
Assessment of Genetic Mutations in Postmenopausal Women With Breast Cancer
Cognitive Impairment in Women With Breast Cancer: Comparison of Adjuvant Therapies
Ductal Carcinoma in Situ: Link Between Estradiol/Testosterone Levels and Increased Risk?
Relationship Between Thyroid Dysfunction and Risk of Breast and Thyroid Cancers
CA 15-3 and Vitamin D: Prognostic Indicators in Patients Treated for Breast Cancer?
Breast Cancer and COVID-19: Alternative Radiation Therapies
Shortened Course of Radiotherapy for Breast Cancer: 5-Year Results From FAST-Forward Trial
Psychosocial Status and Geriatric Abnormalities in Metastatic Breast Cancer
PALB2-Associated Risks of Breast and Other Cancers
Got Milk? Study Finds Potential Link Between Dairy Intake and Breast Cancer
Germline Genetic Testing and Treatment Variation in Women With Breast Cancer
Preventive Tamoxifen Therapy: Are Women Aware of the Risks Along With the Benefits?
Does Extended Adjuvant Capecitabine Improve Survival in Triple-Negative Breast Cancer?
Should There Be an Upper Age Limit for Annual Screening Mammography?
Pathologic Complete Response With Pembrolizumab for Triple-Negative Breast Cancer
Heat Shock Protein 47 and Breast Cancer Metastasis
Risk of Ischemic Heart Disease After Radiotherapy for Breast Cancer
21-Gene Assay Recurrence Score in Predicting Locoregional Recurrence of Breast Cancer
Investigators Map Genetic Variants Linked to Breast Cancer
Second-Line Gemcitabine With Dual Antibody Therapy for ERBB2-Positive Metastatic Breast Cancer
AKT Inhibitor Plus Paclitaxel in Metastatic Triple-Negative Breast Cancer
Microflora and Breast Cancer: Are Some Bacteria Protective and Others Not?
Neoadjuvant Therapy and Eligibility for Breast Conservation in Triple-Negative Disease
Breast Cancer Screening: Personalizing Starting Age Based on Reproductive Factors
Ribociclib Plus Fulvestrant for Advanced Breast Cancer: Update From MONALEESA-3
Does Use of Dietary Supplements During Chemotherapy for Breast Cancer Improve Survival?
Does Treatment Delay Differentially Impact Overall Survival Across Breast Cancer Phenotypes?
Total Cumulative Dose of Chemotherapy and Breast Cancer Survival Rates
Metastatic Sites and Survival Outcomes Among Patients With Advanced Breast Cancer
Use of Supplemental MRI Screening in Women With Extremely Dense Breast Tissue
Proton Beam Radiotherapy for Nodal Irradiation in Patients With Breast Cancer
Update on Prognosis Patterns in Men With Breast Cancer
Breast Cancer Mortality Risk in Women With a History of Thyroid Cancer
GeparSepto Trial: Long-Term Results With Nab-paclitaxel in Early Breast Cancer
Stromal Tumor-Infiltrating Lymphocytes: Prognostic Indicator in Triple-Negative Breast Cancer?
Adjuvant Trastuzumab and Cardiac Toxicities in Patients With Breast Cancer
KATE2 Trial: Updated Overall Survival With Immunotherapy Combination in Advanced Breast Cancer
Machine Learning May Improve Accuracy of Breast Cancer Diagnoses
Update on CDK4/6 and Aromatase Inhibitors in Older Women With Breast Cancer
Is Sex a Contributing Factor to Mortality Disparity in Breast Cancer?
Is Breast Cancer Screening Effective in High-Risk Men?
Insurance and Mortality in Breast and Other Cancers
Final Results of MARIANNE Trial of T-DM1 in HER2-Positive Advanced Breast Cancer
Menopausal Hormone Replacement Therapy and Increased Risk of Breast Cancer
Niraparib Plus Pembrolizumab in Advanced Triple-Negative Breast Cancer
Learning More About Breast Cancer in Adolescents and Young Adults
Breast Cancer Screening in Women With Familial Risk: MRI or Mammography?
Timeliness of Chemotherapy Initiation After Breast Cancer Diagnosis and Survival
TAILORx Trial: Predicting Benefit From Chemotherapy in Early Breast Cancer
Adjuvant Trastuzumab for HER2-Positive Breast Cancer: Results of Two Phase III Trials
HannaH Trial: Subcutaneous Versus Intravenous Trastuzumab in Early Breast Cancer
Role of Lymphoscintigraphy in Sentinel Lymph Node Biopsy for Early Breast Cancer
Pain and Depression in Patients Treated for Breast Cancer
Parity-Associated Gene Expression and Breast Cancer in Premenopausal Women
How an Intervention Trial Addressed Racial Disparities in Treatment of Early-Stage Cancers
Targeting Triple-Negative Breast Cancer With Combination of PARP Inhibitors
Overall Survival With CDK4/6 Inhibitor in Hormone Receptor–Positive Breast Cancer
Niraparib Plus Pembrolizumab in Triple-Negative Breast Cancer: TOPACIO/KEYNOTE-162 Trial
Lifetime Incidence of Brain Metastasis in Elderly Survivors of Breast Cancer
Long-Term Outcomes With Adjuvant Paclitaxel and Trastuzumab in HER2-Positive Breast Cancer
Eribulin Versus Vinorelbine in Locally Recurrent or Metastatic Breast Cancer
Does Primary Care Appointment Time Affect Breast Cancer Screening Rates?
Chronic Opioid Use in Breast Cancer Survivors
Potential Prognostic Marker Identified for Triple Negative Breast Cancer
Genetic Testing in Patients With Breast and Ovarian Cancers
Preoperative Breast MRI and Surgical Outcomes in Local Ductal Carcinoma in Situ
Linking Pregnancy and the Genomic Landscape of Subsequent Breast Cancer
Breast Cancer Risk in Women With BRCA Mutations: Role of Number of Pregnancies
Addition of First-Line Fulvestrant to Anastrozole in Metastatic Breast Cancer
Long-Term Follow-up of Adjuvant Tamoxifen in Women With Breast Cancer
KAMILLA Trial: T-DM1 Safety in HER2-Positive Breast Cancer
Complications After Immediate Implant-Based Breast Cancer Reconstruction
Can Celecoxib Be Used to Treat HER2-Negative Breast Cancer?
Ovarian Function Suppression in Women With Breast Cancer: Degarelix Versus Triptorelin
Extended Letrozole Therapy After Aromatase Inhibitor–Based Therapy in Breast Cancer
Survival Outcomes With Palbociclib and Fulvestrant in Breast Cancer
Addition of Palbociclib to Letrozole in Estrogen Receptor–Positive Breast Cancer
Is There a Link Between Childbirth and Breast Cancer Risk?
Anthracycline Use in Neoadjuvant Therapy for HER2-Positive Breast Cancer
Axillary Radiotherapy as an Alternative to Axillary Lymph Node Dissection for Early Breast Cancer
Cosmetic Outcomes With Irradiation in Stages 0 to II Breast Cancer
Novel Statistical Approach Calculates Risk of Breast Cancer Recurrence in American Women
Extending Aromatase Inhibitor Therapy in Breast Cancer
Continued Benefit of Adding Goserelin to Chemotherapy in Women With Breast Cancer
Combination of Paclitaxel, Sorafenib, and Radiation in Advanced Breast Cancer
Lucitanib for Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
PALB2 Mutation in Hereditary Breast and Ovarian Cancer
How Accurate Are NCDB Comorbidity Assessments in Breast Cancer and Other Resected Tumors?
Racial Differences in Adherence to Endocrine Therapy for Breast Cancer
Update on Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors
Atezolizumab in Metastatic Triple-Negative Breast Cancer: Long-Term Outcomes
Population-Level Genomic Screening for Hereditary Breast Cancer
Alliance Study: Comparing Neoadjuvant Therapy Approaches in HER2-Positive Breast Cancer
Are Fertility-Related Hormone and Breast Cancer Development Linked?
Novel Tool to Predict Risk of Late Distant Recurrence in Patients With Breast Cancer
Update on Trends in Breast Cancer Survival Among Young Women
Impact of Screening on Breast Cancer Mortality Assessed in Danish Study
Can Circulating Tumor Cells Predict Late Recurrence in Breast Cancer?
Long-Term Safety Profile of Palbociclib With Endocrine Therapy
ASCO Clinical Practice Guidelines Updates in Advanced HER2-Positive Breast Cancer
Neoadjuvant Chemotherapy Plus Panitumumab in Inflammatory Breast Cancer
ASCO Guideline Update: Adjuvant Chemotherapy and Targeted Therapy for Breast Cancer
Fear and Worry Over Breast Cancer Among Women Facing Surgical Decisions
Comparing Trastuzumab Biosimilar and Reference Trastuzumab in HER2-Positive Breast Cancer
Update to ASCO/CAP Guidelines on HER2 Testing in Breast Cancer
Association of Prognosis in Early Breast Cancer With Somatic Driver Alterations
Safety of Pregnancy After Estrogen Receptor–Positive Breast Cancer
Clinical Relevance of Multigene Sequencing in Patients With Breast Cancer
Are Long-Term Survivors of Triple-Negative Breast Cancer Being Referred for Genetic Counseling?
Link Between CTC Status and Radiotherapy Benefit in Early-Stage Breast Cancer
Screening for Intracranial Disease in Patients With Metastatic Breast Cancer
Cardiovascular Risks Associated With Breast Cancer and Its Treatments
Are Patients Diagnosed With Breast Cancer Receiving Clinically Indicated Genetic Counseling?
Disparities in Genetic Testing for Hereditary Breast Cancer in the United States
Is Hormone Therapy a Risk Factor for Diabetes in Breast Cancer Survivors?
Novel Second-Line Treatment of Aromatase Inhibitor–Resistant Breast Cancer
Genetic Biomarker as Potential Predictor of Platinum Sensitivity in Triple-Negative Breast Cancer
Addition of Veliparib to Standard Neoadjuvant Therapy in Triple-Negative Breast Cancer
Predicting Risk of Breast Cancer: Automated Versus Clinical Assessment of Breast Density
Postmastectomy Radiation Therapy for Locoregional Control of Breast Cancer
CALOR Trial: Adjuvant Chemotherapy for Isolated Locoregional Recurrence of Breast Cancer
Use of Metronomic Chemotherapy in Older Patients With Metastatic Breast Cancer
Bone Turnover Markers in Metastatic Breast Cancer
Combination Therapy Under Study in Treatment-Resistant Breast Cancer
First-Degree Family History and Breast Cancer Risk in Women Older Than Age 65
Androgen Receptor–Targeted Treatment in Triple-Negative Breast Cancer
Distant and Locoregional Recurrence in Stage II or III Breast Cancer
Updated Results on Neratinib in HER2-Positive Breast Cancer
Correlation Between Breast Cancer Mortality and Advances in Screening and Treatment
Neoadjuvant Versus Adjuvant Chemotherapy in Early Breast Cancer
Dual HER2 Blockade in Metastatic Breast Cancer
Pertuzumab-Containing Neoadjuvant Regimens in HER2-Positive Breast Cancer
Dual HER2-Targeting Treatments for Postmenopausal Women With Metastatic Breast Cancer
Hormonal Birth Control and Invasive Breast Cancer Risk
Safety Profile of Buparlisib Plus Fulvestrant in Advanced Breast Cancer
Survival Benefit of Intense Dose-Dense Chemotherapy in High-Risk Breast Cancer
Use of Duloxetine for Arthralgias Associated With Breast Cancer Treatment
Letrozole Schedules Compared in Postmenopausal Women With Breast Cancer
Textured Breast Implants and Rare Anaplastic Lymphoma
Type 2 Diabetes and Breast Cancer Subtype in African American Women
Cardiac Effects of Trastuzumab Therapy in Patients With HER2-Positive Breast Cancer
Bacterial Imbalances and Breast Cancer
Initial Therapy With Abemaciclib for Advanced Breast Cancer
Effect of 5 Years’ Endocrine Therapy on Breast Cancer Recurrence
cT1–2N0 Breast Cancer: Less- and More-Invasive Treatment Results
Mortality in Elderly, Mentally Ill Breast Cancer Patients
Physicians’ Views on Radiotherapy for Older Women With Early-Stage Breast Cancer
Neoadjuvant Combination Therapy for HER2-Positive Primary Breast Cancer
HER2-Targeted Therapy and Breast Reconstruction
Soy Foods and Breast Cancer Survival
Surgeon Impact on the Decision to Have Contralateral Prophylactic Mastectomy
Investigational AKT Inhibitor in Triple-Negative Breast Cancer
Neoadjuvant Ado-trastuzumab Emtansine vs. Trastuzumab in Early Breast Cancer
Tamoxifen Metabolite Z-Endoxifen in Metastatic Breast Cancer
Current Treatment Approaches for Triple-Negative Breast Cancer
Response to Immunotherapy in Patients With ‘Claudin-Low’ Breast Tumors
Comparing Trastuzumab-Based Regimens in Older Women With Early-Stage Breast Cancer
Surveillance Mammography for Older Survivors of Breast Cancer
Wound Complications After Breast Reconstruction Procedures
Potential Toxicities Associated With CDK4/6 Inhibitors in Breast Cancer
Using Molecular Signature to Identify Indolent Breast Tumors
Oral Vinorelbine in Patients With Endocrine-Pretreated Breast Cancer
Changes in Histology and Breast Cancer Risk
MONARCH 2: Abemaciclib/Fulvestrant in Hormone Receptor–Positive, HER2-Negative Breast Cancer
Adding Pertuzumab to Trastuzumab and Chemotherapy in HER2-Positive Breast Cancer
Final Survival Data From TH3RESA Trial in Breast Cancer
Final Overall Survival Data From EMILIA Trial
Biologic Differences in Invasive Breast Cancers Among Black and White Patients
OlympiAD Trial: Olaparib in HER2-Negative Metastatic Breast Cancer
Additional Surgery After Initial Lumpectomy
Patient Satisfaction With Breast Reconstruction
More Women Living With Metastatic Breast Cancer
Combining Monoclonal Antibodies in HER2-Positive Breast Cancer
ABC Breast Cancer Trials of Adjuvant Taxane With or Without Anthracycline in HER2-Negative Disease
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Optimizing Adherence to Oral Chemotherapy
Steadily Increasing Breast Cancer Rates in Asian Americans
Study Finds Discrepant Decision-Making for Use of 21-Gene Assay in Women With Early-Stage Breast Cancer
Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors
Contralateral Prophylactic Mastectomy Decisions in Patients With Early-Stage Breast Cancer
Identifying Educational Needs of the Multidisciplinary Cancer Team in the Treatment of Metastatic Breast Cancer
A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer
Improved Survival With Higher TIL Values in Advanced HER2-Positive Breast Cancer
A Review of Treatment for Breast Cancer–Related Lymphedema: Paradigms for Clinical Practice
Stereotactic Radiosurgery for Treatment of Brain Metastases
Clinical Trial Data Model: What Can It Offer Health-Care Professionals Who Treat Breast Cancer?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.